Business Context and Reporting Period
Company: InflaRx N.V.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Nine months ended September 30, 2025
Filing Date: November 10, 2025
This filing incorporates by reference the Unaudited Condensed Consolidated Financial Statements and Management's Discussion and Analysis (MD&A) for the nine-month period. The registrant files annual reports under Form 20-F.
Key Financial Metrics
The provided text contains only the cover page and exhibit index of the Form 6-K. It does not include the actual financial statements or MD&A content.
- Revenue: Not provided in source text.
- Profit/Loss: Not provided in source text.
- Cash Flow: Not provided in source text.
- Margins: Not provided in source text.
- Debt and Liquidity: Not provided in source text.
Material Changes
The filing text does not provide specific data to compare against prior periods. Material changes in financial condition or results of operations are detailed in the incorporated exhibits (99.1 and 99.2), which are not included in the input.
Guidance, Outlook, and Risks
No management commentary, forward-looking guidance, risk factors, or discussion of unusual items is present in the provided cover page text. These disclosures are contained within the referenced Exhibit 99.2 (MD&A).
Investor Verification Checklist
- Verify the full content of Exhibit 99.1 for the actual Unaudited Condensed Consolidated Financial Statements.
- Review Exhibit 99.2 for Management's Discussion and Analysis to understand operational results and liquidity status.
- Confirm the incorporation by reference into the specified registration statements (Form S-8 File Nos. 333-221656, 333-240185 and Form F-3 File No. 333-273058).
- Check for any subsequent filings that may supersede the information in this report.